CTRI/2022/11/046970尚未招募3 期
â??A Double-Blind Randomized Clinical Trial to Evaluate the Efficacy of Ayurvedic Formulations NIA/DG/2015/01 and NIA/DG/2020/01 along with Chankramana (Walking) in the Management of Newly Diagnosed Primary Hypertension.â??
ational Institute of Ayurveda Jaipur Rajasthan0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients belonging to both sexes between the age group 18 to 60 years without major comorbidities.
- •2.Patients who already diagnosed as primary hypertension & not taking any antihypertensive medication will be selected.
- •3.Duration of disease- 1-3 month. (Patients whose primary hypertension has been diagnosed before 3 months from the date of screening for this trial will be considered as newly diagnosed cases of primary hypertension.)
- •4.Mild to moderate grade patients of hypertension as per 8th JNC.
- •5.Patients having systolic blood pressure >=140 upto 180 mm of hg and diastolic blood pressure >= 90 upto 110 mm of hg will be selected for the study.
- •6.Patients who are willing to fill the informed consent form.
- •7.Patients who are willing to download suitable mobile applications to record their walking program.
排除标准
- •1.Known cases of Secondary hypertension, renal diseases, Diabetic Mellitus.
- •2.Known cases of Pregnancy induced hypertension.
- •3.Known cases of Ventricular hypertrophy, coarctation of aorta, Portal hypertension, and renal artery stenosis induced hypertension.
- •4.Patients using other antihypertensive medicines of conventional biomedicine / AYUSH systems / any other system.
- •5.Patients using drugs like Oral Contraceptive Pills, steroids.
- •6.Patient with no evidence of any target organ damage.
研究者
相似试验
已完成
2 期
Evaluation of Sildenafil and placebo effects on improvement of clinical and paraclinical measures on patients with severe heart failureCondition 1: Ischemic cardiomyopathy. Condition 2: Dilated cardiomyopathy.Ischaemic cardiomyopathyCongestive cardiomyopathyIRCT201101045544N1Vice chancellor for research shahid Rajaee research center200
已完成
不适用
A Prospective, Randomized, Double-Blind Trial To Evaluate The Role of Topical Anaesthetics In Controlling Pain After Corneal Abrasion In The Emergency DepartmentACTRN12611000448943Southland Hospital180
进行中(未招募)
不适用
Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 5 Days Versus Placebo Versus Telithromycin In the Treatment of Acute Exacerbation of Chronic Bronchitis - NDAcute Exacerbation of Chronic BronchitisMedDRA version: 9.1Level: LLTClassification code 10006458Term: Bronchitis chronicEUCTR2006-003944-42-ITREPLIDYNE, INC.700
进行中(未招募)
不适用
Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 5 Days Versus Placebo in the Treatment of Acute Exacerbation of Chronic Bronchitis”EUCTR2006-003944-42-LVReplidyne, Inc.611
进行中(未招募)
不适用
Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 10 Days Versus Clarithromycin in the Treatment of Community-Acquired Pneumonia”Community-acquired pneumonia. This disease can be defined as an acute lower respiratory tract infection not acquired in a hospital or a long-term care facility.MedDRA version: 9.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaEUCTR2007-003854-28-DEReplidyne, Inc.770
